Streptococcus anginosus group: Clinical significance of an important group of pathogens

Clinical Microbiology Newsletter

Volumn 27, Issue 20, 2005, Pages 155-159

  Gray, Toby ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; SULFONAMIDE;

ABDOMINAL ABSCESS; ABSCESS; ABSCESS DRAINAGE; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; APPENDICITIS; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL FLORA; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; BRAIN ABSCESS; CELLULITIS; CENTRAL NERVOUS SYSTEM INFECTION; CHOLANGITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; EMPYEMA; ENDOCARDIAL DISEASE; GASTROINTESTINAL INFECTION; GENETIC VARIABILITY; HEMOLYSIS; HUMAN; LABORATORY; LIVER ABSCESS; LUNG ABSCESS; LUNG INFECTION; MOLECULAR EVOLUTION; MOUTH ABSCESS; MOUTH INFECTION; MYOSITIS; NONHUMAN; OSTEOMYELITIS; PATHOGENESIS; PERIODONTITIS; PERITONITIS; PHARYNGITIS; REVIEW; SINUSITIS; SKIN ABSCESS; SKIN INFECTION; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS INTERMEDIUS; STREPTOCOCCUS MILLERI; TIME; WOUND INFECTION;

EID: 26244456375     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2005.09.006     Document Type: Article

References (15)

1. Ruoff K. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. Clin. Microbiol. Rev. 1 1988 102 108
2. Belko J. Clinically significant infections with organisms of the Streptococcus milleri group Pediatr. Infect. Dis. J. 21 2002 715 723
3. Antony S.J., Stratton C.W. Streptococcus intermedius group 5th ed. Mandell Principles and practice of infectious diseases 2000 Churchill Livingstone London 2183 2189
4. Mascini E.M., Holm S.E. Streptococci and related genera 2nd ed. Cohen C. Powderly W. Infectious diseases 2004 Mosby London 2133 2152
5. Rubin L.G. False positive detection of group A Streptococcus antigen resulting from cross-reacting Streptococcus intermedius (Streptococcus milleri group) Pediatr. Infect. Dis. J. 15 1996 715 717
6. Chew T.A., Smith J.M.B. Detection of diacetyl (caramel odor) in presumptive identification of the "Streptococcus milleri" group J. Clin. Microbiol. 30 1992 3028 3029
7. Brogan O. Lancefield grouping and smell of caramel for presumptive identification and assessment of pathogenicity in the Streptococcus milleri group J. Clin. Pathol. 50 1997 332 335
8. Clarridge J.E. III Genotypic and phenotypic characterization of "Streptococcus milleri group" isolates from a Veterans Administration hospital population J. Clin. Microbiol. 37 1999 3681 3687
9. Garnier F. Identification of clinically relevant viridans group streptococci to the species level by PCR J. Clin. Microbiol. 35 1997 2337 2341
10. Clarridge J. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus are of different clinical importance and are not equally associated with abscess Clin. Infect. Dis. 32 2001 1511 1515
11. Wanahita A. Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria J. Infect. Dis. 185 2002 85 90
12. Young K.A. Interactions between Eikenella corrodens and "Streptococcus milleri-group" organisms: possible mechanisms of pathogenicity in mixed infections Antonie Leeuwenhoek 69 1996 371 373
13. Shinzato T., Saito A. The Streptococcus milleri group as a cause of pulmonary infections Clin. Infect. Dis. 21 Suppl. 3 1995 S238 S243
14. Nagashima H., Takao A., Maeda N. Abscess forming ability of Streptococcus milleri group: synergistic effect with Fusobacterium nucleatum Microbiol. Immunol. 43 1999 207 216
15. Ruoff K.L., Ferraro M.J. Hydrolytic enzymes of "Streptococcus milleri." J. Clin. Microbiol. 25 1987 1645 1647